CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(continued, in millions)
| Common Stock and Capital in Excess of Par Value |
Retained Earnings (Deficit) |
Accumulated Other Comprehensive Income/(Loss) |
Total Stockholders’ Equity |
|||||||||||||||||
| Issued Shares |
Amount | |||||||||||||||||||
| Successor |
||||||||||||||||||||
| Balances at October 29, 2013 |
— | $ | — | $ | — | $ | — | $ | — | |||||||||||
| Issuance of common stock |
402 | 5,521 | — | — | 5,521 | |||||||||||||||
| Net loss |
— | — | (1,612 | ) | — | (1,612 | ) | |||||||||||||
| Other comprehensive loss |
— | — | — | (27 | ) | (27 | ) | |||||||||||||
| Stock-based compensation expense |
— | 132 | — | — | 132 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Balances at January 31, 2014 |
402 | 5,653 | (1,612 | ) | (27 | ) | 4,014 | |||||||||||||
| Issuance of common stock |
3 | 36 | — | — | 36 | |||||||||||||||
| Net loss |
— | — | (1,221 | ) | — | (1,221 | ) | |||||||||||||
| Other comprehensive income |
— | — | — | 56 | 56 | |||||||||||||||
| Stock-based compensation expense |
— | 72 | — | — | 72 | |||||||||||||||
| Revaluation of redeemable shares |
— | (53 | ) | — | — | (53 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Balances at January 30, 2015 |
405 | 5,708 | (2,833 | ) | 29 | 2,904 | ||||||||||||||
| Issuance of common stock |
— | — | — | — | — | |||||||||||||||
| Net loss |
— | — | (1,104 | ) | — | (1,104 | ) | |||||||||||||
| Other comprehensive loss |
— | — | — | (353 | ) | (353 | ) | |||||||||||||
| Stock-based compensation expense |
— | 72 | — | — | 72 | |||||||||||||||
| Revaluation of redeemable shares |
— | (53 | ) | — | — | (53 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Balances at January 29, 2016 |
405 | $ | 5,727 | $ | (3,937 | ) | $ | (324 | ) | $ | 1,466 | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
The accompanying notes are an integral part of these Consolidated Financial Statements.
- F-10 -
NOTES TO AUDITED CONSOLIDATED FINANCIAL STATEMENTS
